[
    [
        {
            "time": "",
            "original_text": "金徽酒一季度营收5.08亿元，与2019年基本持平",
            "features": {
                "keywords": [
                    "金徽酒",
                    "一季度",
                    "营收",
                    "5.08亿元",
                    "2019年",
                    "持平"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "白酒"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "金徽酒一季度营收5.08亿元，与2019年基本持平",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "恒瑞医药2020年营收、净利同比增长约两成 研发费用创新高",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "2020年",
                    "营收",
                    "净利",
                    "增长",
                    "研发费用",
                    "创新高"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "恒瑞医药2020年营收、净利同比增长约两成 研发费用创新高",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "每日“药”闻|恒瑞医药去年营收277亿，同比增长19%；石药集团PI3K抑制剂申请上市",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "去年",
                    "营收",
                    "277亿",
                    "增长",
                    "19%",
                    "石药集团",
                    "PI3K抑制剂",
                    "申请上市"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "每日“药”闻|恒瑞医药去年营收277亿，同比增长19%；石药集团PI3K抑制剂申请上市",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "港股医药生物板块全线飘红，多只个股涨超3%",
            "features": {
                "keywords": [
                    "港股",
                    "医药生物",
                    "板块",
                    "全线飘红",
                    "个股",
                    "涨超3%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股医药生物板块全线飘红，多只个股涨超3%",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]